In summary, we developed a NIR-responsive macrophage-mediated drug vector and “in situ vaccines” generator, which selectively kills cancer cells by chemo-photodynamic therapy, and boosts cancer immunity via ICD induction simultaneously, achieving enhanced chemo/photo/immunotherapy of primary tumors and bone metastases combined with anti-PD-L1. Here, CD274 is linked to cancer.